Cernusco sul Naviglio, Italy

Lorenzo Pradella


Average Co-Inventor Count = 6.3

ph-index = 2

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 2001-2002

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Lorenzo Pradella: Innovator in Pharmaceutical Chemistry

Introduction

Lorenzo Pradella is a notable inventor based in Cernusco sul Naviglio, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of macrolides and phosphodiesterase inhibitors. With a total of 3 patents to his name, Pradella's work has garnered attention in the scientific community.

Latest Patents

Among his latest patents, Pradella has developed macrolides with anti-inflammatory activity. His patent titled "3′-Des-dimethylamino-9-oxyimino macrolides of formula (I) endowed with anti-inflammatory activity and their pharmaceutical use" showcases his innovative approach to addressing inflammation through pharmaceutical means. Additionally, he has worked on benzazine derivatives as phosphodiesterase 4 inhibitors, further expanding the potential therapeutic applications of his research.

Career Highlights

Lorenzo Pradella is currently associated with Zambon Group S.p.A., a company known for its commitment to advancing healthcare solutions. His role at Zambon has allowed him to collaborate with other talented professionals in the field, enhancing the impact of his inventions.

Collaborations

Pradella has worked alongside esteemed colleagues such as Giancarlo Grancini and Franco Pellacini. Their collaborative efforts have contributed to the successful development of innovative pharmaceutical products.

Conclusion

Lorenzo Pradella's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to influence the development of new therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…